The Valley Desk

ArticleJournal of the American Heart AssociationPublished

Health Care Resource Use and Costs of Rivaroxaban Versus Warfarin Among Nonvalvular Atrial Fibrillation Polypharmacy Patients With Obesity

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Article
Venue
Journal of the American Heart Association
Published
Subject terms
Humans; Atrial Fibrillation; Obesity; Warfarin; Anticoagulants; Treatment Outcome; Polypharmacy; Retrospective Studies; Databases, Factual; Aged; Aged, 80 and over; Middle Aged
PubMed ID
39791405
PubMed Central ID
PMC12054406
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal